EUVIMEDEUVIMED entdecken
Crossref

Mild elevation of extracellular potassium greatly potentiates the effect of sodium channel block to cardiovert atrial fibrillation: The Lankenau approach

Alexander Burashnikov, Charles Antzelevitch

Heart Rhythm · 2023

DOI: 10.1016/j.hrthm.2023.05.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart Rhythm, 2023. Verfasst von Alexander Burashnikov und 1 weiteren Autor:innen. Beteiligte Einrichtung: Lankenau Institute for Medical Research, Wynnewood, Pennsylvania; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylva…. Hauptthemen laut MEDLINE: Atrial Fibrillation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardioversion of atrial fibrillation (AF) is a common clinical necessity, and there is a need for more effective and safe options for acute cardioversion of AF. OBJECTIVE: The purpose of this study was to test the hypothesis that the efficacy and time course of AF cardioversion by sodium channel current (INa) block can be improved by mild elevation of extracellular potassium ([K+]0). METHODS: Using a canine acetylcholine (ACh)-mediated AF model (isolated coronary-perfused right atrial preparations with a rim of right ventricle), we evaluated the ability of flecainide to suppress AF in the presence of [K+]0 ranging from 3 to 8 mM. RESULTS: At [K+]0 of 4 mM (baseline), persistent AF (>1 hour) was induced in 5 of 5 atria in the presence of 0.5 μM ACh. Flecainide alone (1.5 μM) cardioverted 3 of 6 atria at 4 mM [K+]0, 1 of 6 atria at 3 mM [K+]0, 5 of 5 atria at 5 mM and 6 mM [K+]0, and 4 of 4 atria at 8 mM [K+]0. In the absence of flecainide, an increase in [K+]0 from 4 mM to 5, 6, and 8 mM terminated AF in 0 of 5, 2 of 6, and 4 of 4 atria, respectively. The time to conversion was also abbreviated by elevation of [K+]0. After AF termination with flecainide plus elevated [K+]0, AF was either not inducible or brief (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnimalsDogsFlecainideAnti-Arrhythmia AgentsHeart AtriaSodium Channels

Stichwörter der Autor:innen

Atrial fibrillationCardioversionFlecainideHyperkalemiaHypokalemiaPharmacology

Substanzen

FlecainideAnti-Arrhythmia AgentsSodium Channels

Autor:innen und Institutionen

  • Lankenau Institute for Medical Research, Wynnewood, Pennsylvania; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: BurashnikovA@mlhs.org.
  • Lankenau Institute for Medical Research, Wynnewood, Pennsylvania; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania; Lankenau Heart Institute, Main Line Health System, Wynnewood, Pen…

Zitieren

APA

Burashnikov, A., & Antzelevitch, C. (2023). Mild elevation of extracellular potassium greatly potentiates the effect of sodium channel block to cardiovert atrial fibrillation: The Lankenau approach. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2023.05.005

Vancouver

Burashnikov A, Antzelevitch C. Mild elevation of extracellular potassium greatly potentiates the effect of sodium channel block to cardiovert atrial fibrillation: The Lankenau approach. Heart Rhythm. 2023. doi:10.1016/j.hrthm.2023.05.005

BibTeX
@article{Burashnikov2023,
  author = {Burashnikov, Alexander and Antzelevitch, Charles},
  title = {Mild elevation of extracellular potassium greatly potentiates the effect of sodium channel block to cardiovert atrial fibrillation: The Lankenau approach},
  journal = {Heart Rhythm},
  year = {2023},
  doi = {10.1016/j.hrthm.2023.05.005}
}
Kostenlos starten →